Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued ...
Sally Davies, former chief medical officer of England and current UK Special Envoy on Antimicrobial Resistance (AMR), warned in an interview with the ...